A study by Sayer found that probable AD patients who did not respond to donepezil at 6 months exhibited lower salivary AChE activity, supposedly in parallel with a reduced brain cholinergic activity, compared to both AD responders and healthy age-matched controls (Sayer et al., 2004). Here, ACHE is linked to Alzheimer disease.